Harbour BioMed is a global biopharmaceutical company with a strong presence in the United States, Netherlands, China, and Hong Kong, dedicated to developing innovative therapies to address unmet medical needs.
With multiple locations strategically located in key biotech hubs, Harbour BioMed leverages its cutting-edge technology platforms and extensive expertise to drive the discovery and development of novel therapeutics, fostering partnerships and collaborations to accelerate the delivery of life-changing treatments to patients worldwide.
Generated from the website